Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients

References

• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes: HEPATOLOGY, vol. 64, no. X 2016. Hepatology. 2016; 64(1):73–84.
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease – A global public health perspective. J Hepatol. 2019;70(3):531–544.
   PubMed Web of Science ®Google Scholar
• Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7(9):851–861.
   PubMed Web of Science ®Google Scholar
• Quek J, Chan KE, Wong ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023; 8(1):20–30.
   PubMed Web of Science ®Google Scholar
• Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies: obesity and non-alcoholic fatty liver disease. Obes Rev. 2016; 17(6):510–519.
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Widman L, Wahlin S, et al. The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: a swedish nationwide population-based cohort study. United European Gastroenterol J. 2022; 10(5):465–476.
   PubMed Web of Science ®Google Scholar
• Shang Y, Hagström H. Statins are underused in women with NAFLD After cardiovascular events compared with matched control subjects. Clin Gastroenterol Hepatol. 2022; S1542–3565(22):00295–00296.
   Google Scholar
• Shang Y, Nasr P, Widman L, et al. Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology. 2022; 76(5):1495–1505.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011; 11(1):450.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. CLEP. 2015;7:449–490.
   Web of Science ®Google Scholar
• Hayward KL, Johnson AL, Mckillen BJ, et al. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterol. 2020; 7(1):e000485.
   PubMed Web of Science ®Google Scholar
• Hayward KL, Johnson AL, Horsfall LU, et al. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterol. 2021; 8(1):e000572.
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Askling J, Ludvigsson JF, et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol. 2020; 55(10):1205–1210.
   PubMed Web of Science ®Google Scholar
• Corey KE, Kartoun U, Zheng H, et al. Development and validation of an algorithm to identify nonalcoholic fatty liver disease in the electronic medical record. Dig Dis Sci. 2016;61(3):913–919.
   PubMed Web of Science ®Google Scholar
• Forns J, Cainzos‐Achirica M, Hellfritzsch M, et al. Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: a study in three european data sources. Pharmacoepidemiol Drug Saf. 2019; 28(7):965–975.
   PubMed Web of Science ®Google Scholar
• EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004.
   Google Scholar
• Ando Y, Jou JH. Nonalcoholic fatty liver disease and recent guideline updates. Clin Liver Dis. 2021;17(1):23–28.
   Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, , et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313–1321.
   PubMed Web of Science ®Google Scholar
• Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626–637.e7.
   PubMed Web of Science ®Google Scholar
• Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: which cut-offs to use?. Can J Gastroenterol Hepatol 2021;:1–7.
   Google Scholar
• Hamer OW, Aguirre DA, Casola G, et al. Fatty liver: imaging patterns and pitfalls. Radiographics. 2006;26(6):1637–1653.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43(6):1317–1325.
   PubMed Web of Science ®Google Scholar
• McPherson S, Stewart SF, Henderson E, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010; 59(9):1265–1269.
   PubMed Web of Science ®Google Scholar
• Hagström H, Adams LA, Allen AM, et al. Administrative coding in electronic health care record‐based research of NAFLD: an expert panel consensus statement. Hepatology. 2021;74(1):474–482.
   PubMed Web of Science ®Google Scholar
• Danford CJ, Lee JY, Strohbehn IA, et al. Development of an algorithm to identify cases of nonalcoholic steatohepatitis cirrhosis in the electronic health record. Dig Dis Sci. 2021;66(5):1452–1460.
   PubMed Web of Science ®Google Scholar
• Philip G, Djerboua M, Carlone D, et al. Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data. PLOS One. 2020; 15(2):e0229218.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wang Y, Wang J, et al. Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Medicine. 2021; 100(10):e24940.
   PubMed Web of Science ®Google Scholar
• Ammann EM, Kalsekar I, Yoo A, et al. Assessment of obesity prevalence and validity of obesity diagnoses coded in claims data for selected surgical populations: a retrospective, observational study. Medicine. 2019; 98(29):e16438.
   PubMed Web of Science ®Google Scholar
• Martin BJ, Chen G, Graham M, et al. Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res. 2014; 14:70.
   PubMed Web of Science ®Google Scholar
• Khokhar B, Jette N, Metcalfe A, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016; 6(8):e009952.
   PubMed Web of Science ®Google Scholar
• Nedkoff L, Knuiman M, Hung J, et al. Concordance between administrative health data and medical records for diabetes status in coronary heart disease patients: a retrospective linked data study. BMC Med Res Methodol. 2013; 13(1):121.
   PubMed Web of Science ®Google Scholar
• Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017;23(4):290–301.
   PubMed Web of Science ®Google Scholar
• Alexander M, Loomis AK, Fairburn-Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018; 16(1):130.
   PubMed Web of Science ®Google Scholar